Treatment of these diseases, mainly with hormonal therapies and NSAIDs in the case of endometriosis and adenomyosis, as well as the use of oral antibiotics after the confirmation of EC by the CD138 marker, is the current recommended course of action in order to improve the reproductive outcomes of patients. The gene discussed is SDC1; the disease is endometriosis.